Continuous Glucose Monitoring Microcredential

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity is intended for pharmacists interested in continuous glucose monitoring services for patients with diabetes.

At the completion of this activity, participants will be able to:

• Discuss clinical guidelines and evidence supporting use of CGM.
• Compare and contrast continuous glucose monitoring devices.
• Design a treatment regimen based on continuous glucose monitoring data.
• Use the DATAA tool to engage in a discussion with a person with diabetes about their glucose data.
• Describe the process for obtaining third party coverage for continuous glucose monitoring (CGM) for people with diabetes.
• Explain the current procedural terminology (CPT) reimbursement codes related to CGM services and how to utilize them in practice.
• Explain common barriers to continuous glucose monitoring (CGM) use.
• Apply the “identify, configure, collaborate” framework to address common barriers to CGM.

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

The following persons in control of this activity’s content have relevant financial relationships:

• Diana Isaacs:
  • Dexcom, speaker
  • Abbott, speaker
  • Insulet, speaker
  • Sanofi, speaker
  • Sequel, speaker
  • Novo Nordisk, speaker
  • Eli Lilly, speaker 

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.